Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
25.92
-2.48 (-8.73%)
At close: Jul 24, 2026, 4:00 PM EDT
25.92
0.00 (0.00%)
After-hours: Jul 24, 2026, 4:10 PM EDT

Pelthos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
90964---
Market Cap Growth
566.26%2376.40%----
Enterprise Value
116855---
Last Close Price
28.4031.006.41---
PS Ratio
3.435.70----
PB Ratio
2.732.46-1.42---
EV/Sales Ratio
4.195.06----
Debt / Equity Ratio
1.510.90-0.80-0.20-0.15-0.30
Net Debt / Equity Ratio
0.600.43-0.62-0.18-0.13-0.30
Net Debt / EBITDA Ratio
--0.58---0.30-
Net Debt / FCF Ratio
-0.59-0.74-0.29-1.19-0.31-0.69
Asset Turnover
0.380.26----
Quick Ratio
1.751.030.130.020.02-
Current Ratio
2.792.060.340.020.02-
Return on Equity (ROE)
-333.84%-239.55%----
Return on Assets (ROA)
-36.45%-29.79%-645.82%-5663.30%--
Return on Capital Employed (ROCE)
-35.40%-30.10%279.00%106.50%62.50%32.50%
Earnings Yield
-54.24%-45.27%-205.88%---
FCF Yield
-37.20%-23.71%-149.90%---
Buyback Yield / Dilution
-330.61%-237.34%-336.69%-193.25%--
SEC Filings: 10-K · 10-Q